Personal stories

This chronic inflammatory disease causes flareups that make it difficult to breathe. Learn about the two types of asthma, common triggers and how Johnson & Johnson is developing approaches that may lead to better treatments.

The company made the prestigious list for the 24th consecutive year, thanks to its dedication to innovation and social responsibility, among other criteria.

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

Check out this infographic breakdown of the company’s full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.

More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.

Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.

J&J CareCommunity is empowering communities to address one of the most significant barriers to ending tuberculosis (TB): underdiagnosis.

Samatha Curtis from The Good Economy shares four recommendations for impact investors.

Newsletter December 2025